Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$21.3M
-34.2% from 2023
Prescriptions
3,388
$6,292.33 per claim
Patients
785
781 prescribers
Total spending, 2024
$21.3M
$27,157.20 per patient
Medicare prescription drug plans paid $21.3M for Sorafenib in 2024, for 3,388 prescriptions and refills to 785 patients (down 34.2% from 2023). The average cost per claim was $6,292.33.
California had the highest Medicare cost for Sorafenib in 2024: $2.7M for 482 claims, followed by Texas ($2.0M).
Kenneth B Ain, endocrinology in Lexington, KY, had the highest Medicare cost for Sorafenib in 2024: 43 claims costing $468K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kenneth B Ain Lexington, KY | Endocrinology | 43 | Under 11 | $468K |
| Juan M Vazquez Bayamon, PR | Internal Medicine | 22 | Under 11 | $278K |
| Sanjaykumar J Hapani |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 503 | 1,390 | 511 | $16.0M |
| 2023 | 881 | 3,409 | 914 | $32.4M |
| 2024 | 781 | 3,388 | 785 | $21.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 23 |
| Under 11 |
| $248K |
| David H Gallinson Livingston, NJ | Hematology-Oncology | 12 | Under 11 | $197K |
| Mark W Walberg Dallas, TX | Medical Oncology | 11 | Under 11 | $172K |
| Juskaran Chadha Tampa, FL | Hematology-Oncology | 12 | Under 11 | $165K |
| Michael G Douvas Charlottesville, VA | Hematology-Oncology | 13 | Under 11 | $141K |
| Samantha A Armstrong Indianapolis, IN | Hematology-Oncology | 37 | Under 11 | $138K |
| Melissa A Burgess Pittsburgh, PA | Hematology-Oncology | 31 | Under 11 | $132K |
| Yelitza Ruiz Bayamon, PR | Internal Medicine | 12 | Under 11 | $130K |
| Konstantinos Sdrimas Morgantown, WV | Internal Medicine | 14 | Under 11 | $128K |
| Kentaro Minagawa Hershey, PA | Hematology-Oncology | 13 | Under 11 | $123K |
| Karen P Seiter Hawthorne, NY | Hematology-Oncology | 12 | Under 11 | $123K |
| Raymond J Hohl Hershey, PA | Hematology-Oncology | 14 | Under 11 | $121K |
| Carlos A Alemany Orlando, FL | Medical Oncology | 11 | Under 11 | $120K |
| Guillermo Lazo-Diaz McAllen, TX | Medical Oncology | 13 | Under 11 | $118K |
| Steven A Miles Los Angeles, CA | Medical Oncology | 18 | Under 11 | $106K |
| Armen Asik Springfield, MA | Medical Oncology | 11 | Under 11 | $104K |
| Edward Y Chan San Francisco, CA | Internal Medicine | 13 | Under 11 | $101K |
| Lucas Wong Temple, TX | Internal Medicine | 11 | Under 11 | $98K |
| Raja S Mehdi Las Vegas, NV | Medical Oncology | 15 | Under 11 | $93K |
| Michael A Bergeron Lake Charles, LA | Medical Oncology | 14 | Under 11 | $93K |
| Hillary H Wu Carmel, IN | Medical Oncology | 23 | Under 11 | $93K |
| Rajni Sinha Atlanta, GA | Hematology-Oncology | 11 | Under 11 | $90K |
| Timothy L Gillison Springfield, IL | Hematology-Oncology | 20 | Under 11 | $90K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Twi/Upsher | 1,177 | $7.5M |
| Mylan VTRS | 762 | $4.9M |
| Torrent Pharmac TORNTPHARM.NS | 466 | $3.7M |
| Dr.Reddy'S Lab RDY | 545 | $3.2M |
| Teva Pharm TEVA | 438 | $2.0M |